BioSpace News Archive

Policy

FTC, Department of Justice Release New Draft Merger Guidelines

The proposed regulatory framework provides a tougher stance on mergers, impacting industries such as biopharma where the FTC’s recent lawsuit seeks to block Amgen’s Horizon Therapeutics buy.

July 20, 2023
·
2 min read
·
Lisa Munger
Job Trends

Kyowa Kirin Opens New Jersey Headquarters

At almost 80,000 square feet, the addition will allow the Japan-based to create jobs for in-office and hybrid workers in the region.

July 20, 2023
·
2 min read
·
Rosemary Scott
Policy

House Panel Presses FDA on Inspections of Indian, Chinese Plants Amid Drug Shortages

Republican lawmakers have called on the Food and Drug Administration to explain its foreign inspection programs for drug manufacturers in China and India as shortages continue in the U.S.

July 20, 2023
·
2 min read
·
Tristan Manalac
Business

GSK Returns Shigella Vaccine Candidate to LimmaTech as Drug-Resistant Cases Rise

The company is handing back a multivalent Shigella vaccine candidate to LimmaTech Biologics, which spun out in 2015 after GSK’s acquisition of GlycoVaxyn for $190 million.

July 20, 2023
·
2 min read
·
Tristan Manalac
Drug Development

FDA Launches Pilot Program to Develop Better Rare Disease Endpoints

The program—a joint initiative between CDER and CBER—aims to accelerate the development of therapies for rare diseases.

July 20, 2023
·
6 min read
·
Ana Mulero
Business

J&J Exceeds Q2 Expectations, Oncology and Immunology Top Pharma Drivers

The company’s sales guidance for 2023 has been raised to $98.8 billion to $99.8 billion, driven by cancer drugs and medical devices. J&J’s stock rose about 5% in early trading Thursday.

July 20, 2023
·
2 min read
·
Kate Goodwin
Policy

FTC, Amgen Break Off Settlement Talks Over Horizon Deal

The Federal Trade Commission and the company had been in settlement discussions, but those talks have ended as the agency’s antitrust lawsuit seeks to block the Horizon Therapeutics sale.

July 20, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Exploring Leqembi Combinations in the Fight Against Alzheimer’s

With Eisai and Biogen’s Leqembi now fully approved, researchers are exploring combinations—including with therapies targeting tau and microglial function—that could increase its effectiveness.

July 20, 2023
·
6 min read
·
Heather McKenzie
Business

Illumina Cuts Jobs in San Diego, Braces for More

Illumina is laying off 79 workers in San Diego, and according to an internal email, more layoffs will be announced soon.

July 20, 2023
·
1 min read
·
Rosemary Scott
Neoss® Group signs a collaboration agreement with Osstell® AB

Neoss Group, a pioneer in dental implant solutions, is delighted to announce our partnership with Osstell AB, a global organization from Gothenburg, Sweden.

July 20, 2023
·
2 min read